4.7 Article

Copper deprivation enhances the chemosensitivity of pancreatic cancer to rapamycin by mTORC1/2 inhibition

期刊

CHEMICO-BIOLOGICAL INTERACTIONS
卷 382, 期 -, 页码 -

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.cbi.2023.110546

关键词

Copper; CTR1; Pancreatic cancer; mTORC1; mTORC2; Rapamycin

向作者/读者索取更多资源

Cuproplasia, or copper-dependent cell proliferation, has been observed in various solid tumors, and understanding the role of copper transporters in tumor biology could lead to new cancer treatment strategies. In this study, researchers investigated the significance of high-affinity copper transporter-1 (CTR1) in pancreatic cancer and found that hyperactive CTR1 promotes tumor growth and progression by activating the AKT/mTOR signaling pathway. Depletion of intracellular copper inhibited proliferation and angiogenesis of pancreatic cancer cells and improved the anti-cancer effect of an mTOR inhibitor. These findings suggest that targeting CTR1 and copper homeostasis may be a promising approach for cancer therapy.
Cuproplasia, or copper-dependent cell proliferation, has been observed in varieties of solid tumors along with aberrant copper homeostasis. Several studies reported good response of patients to copper chelator assisted neoadjuvant chemotherapy, however, the internal target molecules are still undetermined. Unravel copperassociated tumor signaling would be valuable to forge new links to translate biology of copper into clinical cancer therapies. We evaluated the significance of high-affinity copper transporter-1 (CTR1) by bioinformatic analysis, and in 19 pairs of clinical specimens. Then, with the help of gene interference and chelating agent, enriched signaling pathways were identified by KEGG analysis and immunoblotting. Accompanying biological capability of pancreatic carcinoma-associated proliferation, cell cycle, apoptosis, and angiogenesis were investigated. Furthermore, a combination of mTOR inhibitor and CTR1 suppressor has been assessed in xenografted tumor mouse models. Hyperactive CTR1 was investigated in pancreatic cancer tissues and proven to as the key point of cancer copper homeostasis. Intracellular copper deprivation induced by CTR1 gene knock-down or systematic copper chelation by tetrathiomolybdate suppressed proliferation and angiogenesis of pancreatic cancer cell. PI3K/AKT/mTOR signaling pathway was suppressed by inhibiting the activation of p70(S6)K and pAKT, and finally inhibited mTORC1 and mTORC2 after copper deprivation. Additionally, CTR1 gene silencing successfully improved the anti-cancer effect of mTOR inhibitor rapamycin. Our study reveals that CTR1 contributes to pancreatic tumorigenesis and progression, by up-regulating the phosphorylation of AKT/mTOR signaling molecules. Recovering copper balance by copper deprivation addresses as promising strategy for improved cancer chemotherapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据